当前位置: 首页 >> 检索结果
共有 30706 条符合本次的查询结果, 用时 4.0428875 秒

281. The 8 basic payment methods in health care.

作者: Kevin Quinn.
来源: Ann Intern Med. 2015年163卷4期300-6页
Eight basic payment methods are applicable across all types of health care. Each method is defined by the unit of payment (per time period, beneficiary, recipient, episode, day, service, dollar of cost, or dollar of charges). These methods are more specific than common terms, such as capitation, fee for service, global payment, and cost reimbursement. They also correspond to the division of financial risk between payer and provider, with each method reflecting a risk factor within the health care spending identity. Financial risk gradually shifts from being primarily on providers when payment is per time period to being primarily on payers when payment is per dollar of charges. Method 4 (per episode) marks the line between epidemiologic and treatment risk. The 8 methods are typically combined to balance risk and thus balance incentives between payers and providers. This taxonomy makes it easier to understand trends in payment reform-especially the shifting division of financial risk and the movement toward value-based purchasing-and types of payment reform, such as bundling, accountable care organizations, medical homes, and cost sharing. The taxonomy also enables prediction of conflicts between payers and providers. For each unit of payment, providers are rewarded for increasing units while decreasing their own cost per unit. No payment method is neutral on quality because each encourages and discourages the provision of care overall and in particular situations. Many professional norms and business practices have been established to mitigate undesirable incentives. Health care differs from many other industries in that the unit of payment remains variable and unsettled.

282. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3.

作者: Wendy P Battisti.;Elizabeth Wager.;Lise Baltzer.;Dan Bridges.;Angela Cairns.;Christopher I Carswell.;Leslie Citrome.;James A Gurr.;LaVerne A Mooney.;B Jane Moore.;Teresa Peña.;Carol H Sanes-Miller.;Keith Veitch.;Karen L Woolley.;Yvonne E Yarker.; .
来源: Ann Intern Med. 2015年163卷6期461-4页
This updated Good Publication Practice (GPP) guideline, known as GPP3, builds on earlier versions and provides recommendations for individuals and organizations that contribute to the publication of research results sponsored or supported by pharmaceutical, medical device, diagnostics, and biotechnology companies. The recommendations are designed to help individuals and organizations maintain ethical and transparent publication practices and comply with legal and regulatory requirements. These recommendations cover publications in peer-reviewed journals and presentations (oral or poster) at scientific congresses. The International Society for Medical Publication Professionals invited more than 3000 professionals worldwide to apply for a position on the steering committee, or as a reviewer, for this guideline. The GPP2 authors reviewed all applications (n = 241) and assembled an 18-member steering committee that represented 7 countries and a diversity of publication professions and institutions. From the 174 selected reviewers, 94 sent comments on the second draft, which steering committee members incorporated after discussion and consensus. The resulting guideline includes new sections (Principles of Good Publication Practice for Company-Sponsored Medical Research, Data Sharing, Studies That Should Be Published, and Plagiarism), expands guidance on the International Committee of Medical Journal Editors' authorship criteria and common authorship issues, improves clarity on appropriate author payment and reimbursement, and expands information on the role of medical writers. By following good publication practices (including GPP3), individuals and organizations will show integrity; accountability; and responsibility for accurate, complete, and transparent reporting in their publications and presentations.

283. Intensifying the Focus on the Contribution of the Inanimate Environment to Health Care-Associated Infections.

作者: Tara N Palmore.;David K Henderson.
来源: Ann Intern Med. 2015年163卷8期642-3页

284. Precision Screening for Colorectal Cancer: Promise and Challenges.

作者: Chyke A Doubeni.
来源: Ann Intern Med. 2015年163卷5期390-1页

285. Cleaning Hospital Room Surfaces to Prevent Health Care-Associated Infections: A Technical Brief.

作者: Jennifer H Han.;Nancy Sullivan.;Brian F Leas.;David A Pegues.;Janice L Kaczmarek.;Craig A Umscheid.
来源: Ann Intern Med. 2015年163卷8期598-607页
The cleaning of hard surfaces in hospital rooms is critical for reducing health care-associated infections. This review describes the evidence examining current methods of cleaning, disinfecting, and monitoring cleanliness of patient rooms, as well as contextual factors that may affect implementation and effectiveness. Key informants were interviewed, and a systematic search for publications since 1990 was done with the use of several bibliographic and gray literature resources. Studies examining surface contamination, colonization, or infection with Clostridium difficile, methicillin-resistant Staphylococcus aureus, or vancomycin-resistant enterococci were included. Eighty studies were identified-76 primary studies and 4 systematic reviews. Forty-nine studies examined cleaning methods, 14 evaluated monitoring strategies, and 17 addressed challenges or facilitators to implementation. Only 5 studies were randomized, controlled trials, and surface contamination was the most commonly assessed outcome. Comparative effectiveness studies of disinfecting methods and monitoring strategies were uncommon. Future research should evaluate and compare newly emerging strategies, such as self-disinfecting coatings for disinfecting and adenosine triphosphate and ultraviolet/fluorescent surface markers for monitoring. Studies should also assess patient-centered outcomes, such as infection, when possible. Other challenges include identifying high-touch surfaces that confer the greatest risk for pathogen transmission; developing standard thresholds for defining cleanliness; and using methods to adjust for confounders, such as hand hygiene, when examining the effect of disinfecting methods.

286. Evolving the Palliative Care Workforce to Provide Responsive, Serious Illness Care.

作者: Arif H Kamal.;Jennifer M Maguire.;Diane E Meier.
来源: Ann Intern Med. 2015年163卷8期637-8页

287. Corticosteroids for Severe Community-Acquired Pneumonia: Time to Change Clinical Practice.

作者: Marcos I Restrepo.;Antonio Anzueto.;Antoni Torres.
来源: Ann Intern Med. 2015年163卷7期560-1页

288. Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.

作者: Reed A C Siemieniuk.;Maureen O Meade.;Pablo Alonso-Coello.;Matthias Briel.;Nathan Evaniew.;Manya Prasad.;Paul E Alexander.;Yutong Fei.;Per O Vandvik.;Mark Loeb.;Gordon H Guyatt.
来源: Ann Intern Med. 2015年163卷7期519-28页
Community-acquired pneumonia (CAP) is common and often severe.

289. Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality: A Population-Based Study.

作者: Nisha Nigil Haroon.;J Michael Paterson.;Ping Li.;Robert D Inman.;Nigil Haroon.
来源: Ann Intern Med. 2015年163卷6期409-16页
Ankylosing spondylitis (AS) is a chronic inflammatory arthritis affecting the spine in young adults. It is associated with excess cardiovascular and cerebrovascular morbidity.

290. Web Exclusives. Annals Graphic Medicine: Mom's Flock.

作者: Sharon Rosenzweig.
来源: Ann Intern Med. 2015年163卷3期W135-9页

291. In The Clinic: Hyponatremia.

作者: Dan A Henry.
来源: Ann Intern Med. 2015年163卷3期ITC1-19页

292. Association Among Hypoxemia, Patent Foramen Ovale, and Mediastinal Germ Cell Tumor: A Case Report.

作者: Michael D Offin.;Jonathan Menachem.;Christian Squillante.;Bonnie Ky.;David Vaughn.;Joseph Carver.
来源: Ann Intern Med. 2015年163卷3期243-4页

293. Anticoagulation? Antiplatelet? What's the Score?

作者: Geno J Merli.;Howard H Weitz.
来源: Ann Intern Med. 2015年163卷3期243页

294. Anticoagulation? Antiplatelet? What's the Score?

作者: Jonathan Hager.
来源: Ann Intern Med. 2015年163卷3期243页

295. Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.

作者: John E Cornell.;Cynthia D Mulrow.
来源: Ann Intern Med. 2015年163卷3期242-3页

296. Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.

作者: Alessandro Battaggia.;Alberto Donzelli.;Maria Font.
来源: Ann Intern Med. 2015年163卷3期241-2页

297. Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.

作者: Aris Liakos.;Eleni Athanasiadou.;Maria Mainou.;Eleni Bekiari.;Anna Bettina Haidich.;Evangelos C Rizos.;Apostolos Tsapas.
来源: Ann Intern Med. 2015年163卷3期241页

298. State of Research Funding From the National Institutes of Health for Criminal Justice Health Research.

作者: Cyrus Ahalt.;Emily A Wang.;Brie Williams.
来源: Ann Intern Med. 2015年163卷3期240-1页

299. State of Research Funding From the National Institutes of Health for Criminal Justice Health Research.

作者: Tiffany Lemon.;Anne Spaulding.;Josiah D Rich.
来源: Ann Intern Med. 2015年163卷3期240页

300. First Code.

作者: Christos Theophanous.
来源: Ann Intern Med. 2015年163卷3期238-9页
共有 30706 条符合本次的查询结果, 用时 4.0428875 秒